Global IPS Cell-derived Platelets Market Growth (Status and Outlook) 2025-2031

Publication ID:

LPI07258668

Publication Date:

July 30, 2025

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global IPS Cell-derived Platelets market size is predicted to grow from US$ 2.2 million in 2025 to US$ 3.1 million in 2031; it is expected to grow at a CAGR of 5.8% from 2025 to 2031.
iPS cell-derived platelets are platelets that are differentiated from induced pluripotent stem cells (iPS cells). iPS cells are a type of pluripotent stem cells that are reprogrammed into adult somatic cells (such as skin cells) with similar properties to embryonic stem cells by transfecting specific genes. iPS cells can differentiate into any cell type in the body, including blood cells. In this context, iPS cell-derived platelets refer to platelets that are produced by culturing precursor cells derived from iPS cells (such as platelet-producing megakaryocytes). These platelets can be cultured in vitro and used in the medical field to replace donor platelets, especially for the treatment of diseases caused by insufficient platelet count or abnormal function.
iPS cell-derived platelets, as an important breakthrough in the field of regenerative medicine, have received widespread attention in recent years. iPS cells (induced pluripotent stem cells) have extremely strong differentiation potential and can generate pluripotent stem cells similar to embryonic stem cells by reprogramming adult somatic cells. This technology not only provides new ideas for cell therapy and tissue repair, but also opens up new directions for the production of blood products. By deriving platelets from iPS cells, new treatment options can be provided for patients with diseases such as platelet deficiency and platelet dysfunction, and the problem of global shortage of blood products can also be alleviated.
At present, the research on iPS cell-derived platelets is still in its early stages, and many research institutions and biotechnology companies are committed to the development and optimization of this technology. Platelets, as a cell with special functions, are responsible for hemostasis and coagulation in the body, so the safety and effectiveness of their clinical application are crucial.
At present, the research on iPS cell-derived platelets is mainly concentrated in the laboratory and preclinical stages. Some research institutions and biopharmaceutical companies in Japan, the United States and Europe have made some progress in this field. However, the current production of iPS cell-derived platelets still faces some difficulties, including complex production processes, high costs, and the fact that the functions of platelets are still different from those of natural platelets.
Despite this, the prospects for the iPS cell-derived platelet market are still broad. The global blood products market has grown year by year, but the shortage of platelet supply has always been an issue that cannot be ignored. A large number of platelets are needed every year to meet clinical needs, especially in groups such as cancer patients, blood disease patients, and surgical patients. Traditional blood products rely on voluntary donors, but due to the limited number of donors, the supply of platelets is often in short supply. The emergence of iPS cell-derived platelets may break this limitation and provide a more stable and efficient alternative to meet market demand.
The 鈥淚PS Cell-derived Platelets Industry Forecast鈥� looks at past sales and reviews total world IPS Cell-derived Platelets sales in 2024, providing a comprehensive analysis by region and market sector of projected IPS Cell-derived Platelets sales for 2025 through 2031. With IPS Cell-derived Platelets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world IPS Cell-derived Platelets industry.
This Insight Report provides a comprehensive analysis of the global IPS Cell-derived Platelets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on IPS Cell-derived Platelets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global IPS Cell-derived Platelets market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for IPS Cell-derived Platelets and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global IPS Cell-derived Platelets.
This report presents a comprehensive overview, market shares, and growth opportunities of IPS Cell-derived Platelets market by product type, application, key players and key regions and countries.
Segmentation by Type:
In Vivo Regeneration
In Vitro Regeneration
Segmentation by Application:
Cancer
Blood Disease
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Megakaryon Corporation
Renerval Therapeutics
Xueji Shengwu
Help Therapeutics
Cynata Therapeutics

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global IPS Cell-derived Platelets Market Size (2020-2031)
2.1.2 IPS Cell-derived Platelets Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for IPS Cell-derived Platelets by Country/Region (2020, 2024 & 2031)
2.2 IPS Cell-derived Platelets Segment by Type
2.2.1 In Vivo Regeneration
2.2.2 In Vitro Regeneration
2.3 IPS Cell-derived Platelets Market Size by Type
2.3.1 IPS Cell-derived Platelets Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global IPS Cell-derived Platelets Market Size Market Share by Type (2020-2025)
2.4 IPS Cell-derived Platelets Segment by Application
2.4.1 Cancer
2.4.2 Blood Disease
2.4.3 Others
2.5 IPS Cell-derived Platelets Market Size by Application
2.5.1 IPS Cell-derived Platelets Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global IPS Cell-derived Platelets Market Size Market Share by Application (2020-2025)
3 IPS Cell-derived Platelets Market Size by Player
3.1 IPS Cell-derived Platelets Market Size Market Share by Player
3.1.1 Global IPS Cell-derived Platelets Revenue by Player (2020-2025)
3.1.2 Global IPS Cell-derived Platelets Revenue Market Share by Player (2020-2025)
3.2 Global IPS Cell-derived Platelets Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 IPS Cell-derived Platelets by Region
4.1 IPS Cell-derived Platelets Market Size by Region (2020-2025)
4.2 Global IPS Cell-derived Platelets Annual Revenue by Country/Region (2020-2025)
4.3 Americas IPS Cell-derived Platelets Market Size Growth (2020-2025)
4.4 APAC IPS Cell-derived Platelets Market Size Growth (2020-2025)
4.5 Europe IPS Cell-derived Platelets Market Size Growth (2020-2025)
4.6 Middle East & Africa IPS Cell-derived Platelets Market Size Growth (2020-2025)
5 Americas
5.1 Americas IPS Cell-derived Platelets Market Size by Country (2020-2025)
5.2 Americas IPS Cell-derived Platelets Market Size by Type (2020-2025)
5.3 Americas IPS Cell-derived Platelets Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC IPS Cell-derived Platelets Market Size by Region (2020-2025)
6.2 APAC IPS Cell-derived Platelets Market Size by Type (2020-2025)
6.3 APAC IPS Cell-derived Platelets Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe IPS Cell-derived Platelets Market Size by Country (2020-2025)
7.2 Europe IPS Cell-derived Platelets Market Size by Type (2020-2025)
7.3 Europe IPS Cell-derived Platelets Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa IPS Cell-derived Platelets by Region (2020-2025)
8.2 Middle East & Africa IPS Cell-derived Platelets Market Size by Type (2020-2025)
8.3 Middle East & Africa IPS Cell-derived Platelets Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global IPS Cell-derived Platelets Market Forecast
10.1 Global IPS Cell-derived Platelets Forecast by Region (2026-2031)
10.1.1 Global IPS Cell-derived Platelets Forecast by Region (2026-2031)
10.1.2 Americas IPS Cell-derived Platelets Forecast
10.1.3 APAC IPS Cell-derived Platelets Forecast
10.1.4 Europe IPS Cell-derived Platelets Forecast
10.1.5 Middle East & Africa IPS Cell-derived Platelets Forecast
10.2 Americas IPS Cell-derived Platelets Forecast by Country (2026-2031)
10.2.1 United States Market IPS Cell-derived Platelets Forecast
10.2.2 Canada Market IPS Cell-derived Platelets Forecast
10.2.3 Mexico Market IPS Cell-derived Platelets Forecast
10.2.4 Brazil Market IPS Cell-derived Platelets Forecast
10.3 APAC IPS Cell-derived Platelets Forecast by Region (2026-2031)
10.3.1 China IPS Cell-derived Platelets Market Forecast
10.3.2 Japan Market IPS Cell-derived Platelets Forecast
10.3.3 Korea Market IPS Cell-derived Platelets Forecast
10.3.4 Southeast Asia Market IPS Cell-derived Platelets Forecast
10.3.5 India Market IPS Cell-derived Platelets Forecast
10.3.6 Australia Market IPS Cell-derived Platelets Forecast
10.4 Europe IPS Cell-derived Platelets Forecast by Country (2026-2031)
10.4.1 Germany Market IPS Cell-derived Platelets Forecast
10.4.2 France Market IPS Cell-derived Platelets Forecast
10.4.3 UK Market IPS Cell-derived Platelets Forecast
10.4.4 Italy Market IPS Cell-derived Platelets Forecast
10.4.5 Russia Market IPS Cell-derived Platelets Forecast
10.5 Middle East & Africa IPS Cell-derived Platelets Forecast by Region (2026-2031)
10.5.1 Egypt Market IPS Cell-derived Platelets Forecast
10.5.2 South Africa Market IPS Cell-derived Platelets Forecast
10.5.3 Israel Market IPS Cell-derived Platelets Forecast
10.5.4 Turkey Market IPS Cell-derived Platelets Forecast
10.6 Global IPS Cell-derived Platelets Forecast by Type (2026-2031)
10.7 Global IPS Cell-derived Platelets Forecast by Application (2026-2031)
10.7.1 GCC Countries Market IPS Cell-derived Platelets Forecast
11 Key Players Analysis
11.1 Megakaryon Corporation
11.1.1 Megakaryon Corporation Company Information
11.1.2 Megakaryon Corporation IPS Cell-derived Platelets Product Offered
11.1.3 Megakaryon Corporation IPS Cell-derived Platelets Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Megakaryon Corporation Main Business Overview
11.1.5 Megakaryon Corporation Latest Developments
11.2 Renerval Therapeutics
11.2.1 Renerval Therapeutics Company Information
11.2.2 Renerval Therapeutics IPS Cell-derived Platelets Product Offered
11.2.3 Renerval Therapeutics IPS Cell-derived Platelets Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Renerval Therapeutics Main Business Overview
11.2.5 Renerval Therapeutics Latest Developments
11.3 Xueji Shengwu
11.3.1 Xueji Shengwu Company Information
11.3.2 Xueji Shengwu IPS Cell-derived Platelets Product Offered
11.3.3 Xueji Shengwu IPS Cell-derived Platelets Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Xueji Shengwu Main Business Overview
11.3.5 Xueji Shengwu Latest Developments
11.4 Help Therapeutics
11.4.1 Help Therapeutics Company Information
11.4.2 Help Therapeutics IPS Cell-derived Platelets Product Offered
11.4.3 Help Therapeutics IPS Cell-derived Platelets Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Help Therapeutics Main Business Overview
11.4.5 Help Therapeutics Latest Developments
11.5 Cynata Therapeutics
11.5.1 Cynata Therapeutics Company Information
11.5.2 Cynata Therapeutics IPS Cell-derived Platelets Product Offered
11.5.3 Cynata Therapeutics IPS Cell-derived Platelets Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Cynata Therapeutics Main Business Overview
11.5.5 Cynata Therapeutics Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂